Adult stem cells and skeletal muscle regeneration

Current Gene Therapy

Volumn 15, Issue 4, 2015, Pages 348-363

  Costamagna, Domiziana ^a,b   Berardi, Emanuele ^a   Ceccarelli, Gabriele ^c   Sampaolesi, Maurilio ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adult stem cells; Muscular dystrophy; Skeletal muscle regeneration

Indexed keywords

MICRORNA;

ADULT STEM CELL; ARTICLE; BONE MARROW CELL; CLINICAL TRIAL (TOPIC); EXOSOME; FIBRO ADIPOGENIC PROGENITOR CELL; HUMAN; LEYDIG CELL; MESENCHYMAL STEM CELL; MESOANGIOBLAT; MUSCLE ATROPHY; MUSCLE INJURY; MUSCLE REGENERATION; MUSCLE STEM CELL; MUSCULAR DYSTROPHY; NONHUMAN; PERICYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); SATELLITE CELL; SIDE POPULATION CELL; SK 34 CELL; TCF4 POSITIVE FIBROBLAST; TELOCYTE; ANIMAL; CYTOLOGY; DISEASE MODEL; GENE EXPRESSION REGULATION; MUSCULAR DYSTROPHIES; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALIA;

ADULT STEM CELLS; ANIMALS; DISEASE MODELS, ANIMAL; EXOSOMES; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; REGENERATION; STEM CELL TRANSPLANTATION;

EID: 84938694936     PISSN: 15665232     EISSN: 18755631     Source Type: Journal    
DOI: 10.2174/1566523215666150630121024     Document Type: Article

References (182)

1. Nedachi T, Hatakeyama H, Kono T, Sato M, et al. Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes. Am J Physiol Endocrinol Metab 2009 Oct; 297[4]:E866- 78.
2. Pizza FX, Peterson JM, Baas JH, et al. Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice. J Physiol 2005 Feb 1; 562[Pt 3]:899-913.
3. Brigitte M, Schilte C, Plonquet A, et al. Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury. Arthritis Rheum 2010 Jan; 62[1]:268- 79.
4. Swirski FK, Nahrendorf M, Etzrodt M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Sci 2009 Jul 31; 325[5940]:612-6.
5. Quattrocelli M, Cassano M, Crippa S, et al. Cell therapy strategies and improvements for muscular dystrophy. Cell Death Differ 2010 Aug; 17[8]:1222-9.
6. Chazaud B, Brigitte M, Yacoub-Youssef H, et al. Dual and beneficial roles of macrophages during skeletal muscle regeneration. Exerc Sport Sci Rev 2009 Jan; 37[1]:18-22.
7. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004 Dec; 25[12]:677-86.
8. Bosurgi L, Corna G, Vezzoli M, et al. Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury. J Immunol 2012 Jun 15; 188[12]:6267-77.
9. Gautier EL, Shay T, Miller J, et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 2012 Nov; 13[11]:1118-28.
10. Arnold L, Henry A, Poron F, et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007 May 14; 204[5]:1057-69.
11. Sugama K, Suzuki K, Yoshitani K, et al. IL-17, neutrophil activation and muscle damage following endurance exercise. Exerc Immunol Rev 2012; 18:116-27.
12. Kohno S, Ueji T, Abe T, et al. Rantes secreted from macrophages disturbs skeletal muscle regeneration after cardiotoxin injection in Cbl-b-deficient mice. Muscle Nerve 2011 Feb; 43[2]:223-9.
13. Gorospe JR, Nishikawa BK, Hoffman EP. Recruitment of mast cells to muscle after mild damage. J Neurol Sci 1996 Jan; 135[1]:10-7.
14. Horsley V, Jansen KM, Mills ST, Pavlath GK. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 2003 May 16; 113[4]:483-94.
15. Tidball JG, Villalta SA. Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 2010 May; 298[5]:R1173-87.
16. Scaal M, Christ B. Formation and differentiation of the avian dermomyotome. Anat Embryol [Berl] 2004 Sep; 208[6]:411-24.
17. Esner M, Meilhac SM, Relaix F, Nicolas JF, et al. Smooth muscle of the dorsal aorta shares a common clonal origin with skeletal muscle of the myotome. Deve 2006 Feb; 133[4]:737-49.
18. Harel I, Nathan E, Tirosh-Finkel L, et al. Distinct origins and genetic programs of head muscle satellite cells. Dev Cell 2009 Jun; 16[6]:822-32.
19. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961 Feb;9:493-5.
20. Hawke TJ, Garry DJ. Myogenic satellite cells: physiology to molecular biology. J Appl Physiol 2001 Aug; 91[2]:534-51.
21. Yin H, Price F, Rudnicki MA. Satellite cells and the muscle stem cell niche. Physiol Rev 2013 Jan; 93[1]:23-67.
22. Kuang S, Kuroda K, Le Grand F, Rudnicki MA. Asymmetric selfrenewal and commitment of satellite stem cells in muscle. Cell 2007 Jun 1; 129[5]:999-1010.
23. Musaro A, Barberi L. Isolation and culture of mouse satellite cells. Methods Mol Biol 2010; 633:101-11.
24. Montarras D, Morgan J, Collins C, et al. Direct isolation of satellite cells for skeletal muscle regeneration. Sci 2005 Sep 23; 309[5743]:2064-7.
25. Irintchev A, Zeschnigk M, Starzinski-Powitz A, et al. Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Dev Dyn 1994 Apr; 199[4]:326-37.
26. Bockhold KJ, Rosenblatt JD, Partridge TA. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve 1998 Feb; 21[2]:173-83.
27. Allen RE, Sheehan SM, Taylor RG, et al. Hepatocyte growth factor activates quiescent skeletal muscle satellite cells in vitro. J Cell Physiol 1995 Nov; 165[2]:307-12.
28. Ratajczak MZ, Majka M, Kucia M, et al. Expression of functional CXCR4 by muscle satellite cells and secretion of SDF-1 by muscle-derived fibroblasts is associated with the presence of both muscle progenitors in bone marrow and hematopoietic stem/progenitor cells in muscles. Stem Cells 2003; 21[3]:363-71.
29. Cornelison DD, Filla MS, Stanley HM, et al. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 2001 Nov 1; 239[1]:79-94.
30. Volonte D, Liu Y, Galbiati F. The modulation of caveolin-1 expression controls satellite cell activation during muscle repair. Faseb J 2005 Feb; 19[2]:237-9.
31. Fukada S, Uezumi A, Ikemoto M, et al. Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells 2007 Oct; 25[10]:2448-59.
32. Beauchamp JR, Heslop L, Yu DS, et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000 Dec 11; 151[6]:1221-34.
33. Burkin DJ, Kaufman SJ. The alpha7beta1 integrin in muscle development and disease. Cell Tissue Res 1999 Apr; 296[1]:183- 90.
34. Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, et al. Pax7 is required for the specification of myogenic satellite cells. Cell 2000 Sep 15; 102[6]:777-86.
35. Kadi F, Eriksson A, Holmner S, Thornell LE. Effects of anabolic steroids on the muscle cells of strength-trained athletes. Med Sci Sports Exerc 1999 Nov; 31[11]:1528-34.
36. Schultz E. Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol 1996 Apr 10; 175[1]:84-94.
37. Ono Y, Calhabeu F, Morgan JE, et al. BMP signalling permits population expansion by preventing premature myogenic differentiation in muscle satellite cells. Cell Death Differ 2011 Feb; 18[2]:222-34.
38. Shinin V, Gayraud-Morel B, et al. Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol 2006 Jul; 8[7]:677-87.
39. Lansdorp PM. Immortal strands? Give me a break. Cell 2007 Jun 29; 129[7]:1244-7.
40. Mouly V, Aamiri A, Bigot A, et al. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 2005 May; 184[1]:3-15.
41. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Sci 1997 Apr 4; 276[5309]:71-4.
42. Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status. Stem Cells 2010 Mar 31; 28[3]:585-96.
43. Nixon AJ, Watts AE, Schnabel LV. Cell- and gene-based approaches to tendon regeneration. J Shoulder Elbow Surg 2012 Feb; 21[2]:278-94.
44. Ferrari G, Cusella-De Angelis G, Coletta M, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Sci 1998 Mar 6; 279[5356]:1528-30.
45. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nat 1999 Sep 23; 401[6751]:390-4.
46. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Sci 2005 Jul 8; 309[5732]:314-7.
47. Sims DE. The pericyte--a review. Tissue Cell 1986; 18[2]:153-74.
48. Ozerdem U, Grako KA, Dahlin-Huppe K, et al. NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis. Dev Dyn 2001 Oct; 222[2]:218-27.
49. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Sci 1997 Jul 11; 277[5323]:242-5.
50. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007 Mar; 9[3]:255-67.
51. Chen WC, Saparov A, Corselli M, et al. Isolation of blood-vesselderived multipotent precursors from human skeletal muscle. J Vis Exp 2014[90]:e51195.
52. Cossu G, Bianco P. Mesoangioblasts--vascular progenitors for extravascular mesodermal tissues. Curr Opin Genet Dev 2003 Oct; 13[5]:537-42.
53. Sampaolesi M, Torrente Y, Innocenzi A, et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Sci 2003 Jul 25; 301[5632]:487-92.
54. Tonlorenzi R, Dellavalle A, Schnapp E, Cossu G, Sampaolesi M. Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. Curr Protoc Stem Cell Biol 2007 Dec; in chapter 2: Unit 2B 1.
55. De Angelis L, Berghella L, Coletta M, et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 1999 Nov 15; 147[4]:869-78.
56. Minasi MG, Riminucci M, De Angelis L, et al. The mesoangioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Develop 2002 Jun; 129[11]:2773-83.
57. Quattrocelli M, Palazzolo G, Perini I, et al. Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles. Methods Mol Biol 2012; 798:65-76.
58. Holmes C, Stanford WL. Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 2007 Jun; 25[6]:1339-47.
59. Caplan AI. All MSCs are pericytes? Cell Stem Cell 2008 Sep 11; 3[3]:229-30.
60. Roobrouck VD, Clavel C, Jacobs SA, et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 2011 May; 29[5]:871-82.
61. English K, Tonlorenzi R, Cossu G, Wood KJ. Mesoangioblasts suppress T cell proliferation through IDO and PGE-2-dependent pathways. Stem Cells Dev 2013 Feb 1; 22[3]:512-23.
62. Relaix F. Skeletal muscle progenitor cells: from embryo to adult. Cell Mol Life Sci 2006 Jun; 63[11]:1221-5.
63. Mitchell KJ, Pannerec A, Cadot B, et al. Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol 2010 Mar; 12[3]:257- 66.
64. Nicolas N, Marazzi G, Kelley K, Sassoon D. Embryonic deregulation of muscle stress signaling pathways leads to altered postnatal stem cell behavior and a failure in postnatal muscle growth. Dev Biol 2005 May 15; 281[2]:171-83.
65. Qu-Petersen Z, Deasy B, Jankowski R, et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002 May 27; 157[5]:851-64.
66. Lu A, Cummins JH, Pollett JB, et al. Isolation of myogenic progenitor populations from Pax7-deficient skeletal muscle based on adhesion characteristics. Gene Ther 2008 Aug; 15[15]:1116-25.
67. Peng H, Huard J. Muscle-derived stem cells for musculoskeletal tissue regeneration and repair. Transpl Immunol 2004 Apr; 12[3- 4]:311-9.
68. Tanaka KK, Hall JK, Troy AA, Cornelison DD, et al. Syndecan-4- expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 2009 Mar 6; 4[3]:217-25.
69. Andersen DC, Kristiansen GQ, Jensen L, Fuchtbauer EM, Schroder HD, Jensen CH. Quantitative gene expression profiling of CD45+ and CD45- skeletal muscle-derived side population cells. Cytometry A 2012 Jan; 81[1]:72-80.
70. Schienda J, Engleka KA, Jun S, et al. Somitic origin of limb muscle satellite and side population cells. Proc Natl Acad Sci U S A 2006 Jan 24; 103[4]:945-50.
71. Pacak CA, Eddy MT, Woodhull L, et al. Microcarrier-based expansion of adult murine side population stem cells. PLoS One 2013; 8[1]:e55187.
72. Motohashi N, Asakura A. Molecular Regulation of Muscle Satellite Cell Self-Renewal. J Stem Cell Res Ther 2012 Nov; Suppl 11.
73. Tamaki T, Akatsuka A, Okada Y, et al. Growth and differentiation potential of main- and side-population cells derived from murine skeletal muscle. Exp Cell Res 2003 Nov 15; 291[1]:83-90.
74. Tamaki T, Uchiyama Y, Akatsuka A. Plasticity and physiological role of stem cells derived from skeletal muscle interstitium: contribution to muscle fiber hyperplasia and therapeutic use. Curr Pharm Des 2010; 16[8]:956-67.
75. Tamaki T, Okada Y, Uchiyama Y, et al. Synchronized reconstitution of muscle fibers, peripheral nerves and blood vessels by murine skeletal muscle-derived CD34[-]/45 [-] cells. Histochem Cell Biol 2007 Oct; 128[4]:349-60.
76. Tamaki T, Hirata M, Soeda S, et al. Preferential and comprehensive reconstitution of severely damaged sciatic nerve using murine skeletal muscle-derived multipotent stem cells. PLoS One 2014; 9[3]:e91257.
77. Brack AS, Conboy MJ, Roy S, et al. Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Sci 2007 Aug 10; 317[5839]:807-10.
78. Joe AW, Yi L, Natarajan A, et al. Muscle injury activates resident fibro/adipogenic progenitors that facilitate myogenesis. Nat Cell Biol 2010 Feb; 12[2]:153-63.
79. Uezumi A, Fukada S, Yamamoto N, et al. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol [2010 Feb; 12[2]:143- 52.
80. Mozzetta C, Consalvi S, Saccone V, et al. Fibroadipogenic progenitors mediate the ability of HDAC inhibitors to promote regeneration in dystrophic muscles of young, but not old Mdx mice. EMBO Mol Med 2013 Apr; 5[4]:626-39.
81. Popescu LM, Gherghiceanu M, Suciu LC, et al. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res 2011 Sep; 345[3]:391-403.
82. Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts 2014 Oct; 5[5]:353-69.
83. Bojin FM, Gavriliuc OI, Cristea MI et al. Telocytes within human skeletal muscle stem cell niche. J Cell Mol Med 2011 Oct; 15[10]:2269-72.
84. Mathew SJ, Hansen JM, Merrell AJ, et al. Connective tissue fibroblasts and Tcf4 regulate myogenesis. Develop 2011 Jan; 138[2]:371-84.
85. Murphy MM, Lawson JA, Mathew SJ, et al. Satellite cells, connective tissue fibroblasts and their interactions are crucial for muscle regeneration. Develop 2011 Sep; 138[17]:3625-37.
86. Sambasivan R, Yao R, Kissenpfennig A, et al. Pax7-expressing satellite cells are indispensable for adult skeletal muscle regeneration. Develop 2011 Sep; 138[17]:3647-56.
87. Rosenblatt JD, Yong D, Parry DJ. Satellite cell activity is required for hypertrophy of overloaded adult rat muscle. Muscle Nerve 1994 Jun; 17[6]:608-13.
88. Adams GR, Caiozzo VJ, Haddad F, et al. Cellular and molecular responses to increased skeletal muscle loading after irradiation. Am J Physiol Cell Physiol 2002 Oct; 283[4]:C1182-95.
89. Parise G, McKinnell IW, Rudnicki MA. Muscle satellite cell and atypical myogenic progenitor response following exercise. Muscle Nerve 2008 May; 37[5]:611-9.
90. Nagata Y, Partridge TA, Matsuda R, Zammit PS. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J Cell Biol 2006 Jul 17; 174[2]:245-53.
91. Young N, Van Brocklyn JR. Signal transduction of sphingosine-1- phosphate G protein-coupled receptors. ScientificWorld J 2006; 6:946-66.
92. Nagata Y, Ohashi K, Wada E, et al. Sphingosine-1-phosphate mediates epidermal growth factor-induced muscle satellite cell activation. Exp Cell Res 2014 Aug 1; 326[1]:112-24.
93. Loh KC, Leong WI, Carlson ME, et al. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS One 2012; 7[5]:e37218.
94. Tatsumi R, Anderson JE, Nevoret CJ, et al. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 1998 Feb 1; 194[1]:114-28.
95. Bjornson CR, Cheung TH, Liu L, et al. Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells 2012 Feb; 30[2]:232-42.
96. Fukada S, Yamaguchi M, Kokubo H, et al. Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers. Develop 2011 Nov; 138[21]:4609- 19.
97. Brack AS, Conboy IM, Conboy MJ, et al. A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis. Cell Stem Cell 2008 Jan 10; 2[1]:50-9.
98. Le Grand F, Jones AE, Seale V, et al. Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 2009 Jun 5; 4[6]:535-47.
99. Bentzinger CF, von Maltzahn J, Dumont NA, et al. Wnt7a stimulates myogenic stem cell motility and engraftment resulting in improved muscle strength. J Cell Biol 2014 Apr 14; 205[1]:97-111.
100. Taylor-Jones JM, McGehee RE, Rando TA, Lecka-Czernik B, Lipschitz DA, Peterson CA. Activation of an adipogenic program in adult myoblasts with age. Mech Ageing Dev 2002 Mar 31; 123[6]:649-61.
101. Vertino AM, Taylor-Jones JM, Longo KA, et al. Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts. Mol Biol Cell 2005 Apr; 16[4]:2039-48.
102. Conboy IM, Conboy MJ, Smythe GM, Rando TA. Notch-mediated restoration of regenerative potential to aged muscle. Sci 2003 Nov 28; 302[5650]:1575-7.
103. Bouchentouf M, Benabdallah BF, Bigey P, et al. Vascular endothelial growth factor reduced hypoxia-induced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 2008 Mar; 15[6]:404-14.
104. Tatsumi R, Liu X, Pulido A, et al. Satellite cell activation in stretched skeletal muscle and the role of nitric oxide and hepatocyte growth factor. Am J Physiol Cell Physiol 2006 Jun; 290[6]:C1487- 94.
105. Halevy O, Piestun Y, Allouh MZ et al. Pattern of Pax7 expression during myogenesis in the posthatch chicken establishes a model for satellite cell differentiation and renewal. Dev Dyn 2004 Nov; 231[3]:489-502.
106. Cassano M, Biressi S, Finan A, et al. Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. PLoS One 2008;3[9]:e3223.
107. Floss T, Arnold HH, Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev 1997 Aug 15; 11[16]:2040-51.
108. Kastner S, Elias MC, Rivera AJ, Yablonka-Reuveni Z. Gene expression patterns of the fibroblast growth factors and their receptors during myogenesis of rat satellite cells. J Histochem Cytochem 2000 Aug; 48[8]:1079-96.
109. Cassano M, Dellavalle A, Tedesco FS, et al. Alpha sarcoglycan is required for FGF-dependent myogenic progenitor cell proliferation in vitro and in vivo. Develop 2011 Oct; 138[20]:4523-33.
110. Philippou A, Maridaki M, Halapas A, Koutsilieris M. The role of the insulin-like growth factor 1 [IGF-1] in skeletal muscle physiology. In vivo 2007 Jan-Feb; 21[1]:45-54.
111. Florini JR, Ewton DZ, Roof SL. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol Endocrinol 1991 May; 5[5]:718- 24.
112. Song K, Wang H, Krebs TL, Danielpour D. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. Embo J 2006 Jan 11; 25[1]:58-69.
113. Tureckova J, Wilson EM, Cappalonga JL, Rotwein P. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J Biol Chem 2001 Oct 19; 276[42]:39264-70.
114. Gonzalez I, Tripathi G, Carter EJ, et al. Akt2, a novel functional link between p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in myogenesis. Mol Cell Biol 2004 May; 24[9]:3607-22.
115. Coolican SA, Samuel DS, Ewton DZ, et al. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem 1997 Mar 7; 272[10]:6653-62.
116. Musaro A, McCullagh K, Paul A, et al. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001 Feb; 27[2]:195-200.
117. Lafreniere JF, Caron MC, Skuk D, et al. Growth factor coinjection improves the migration potential of monkey myogenic precursors without affecting cell transplantation success. Cell Transplant 2009; 18[7]:719-30.
118. Tedesco FS, Cossu G. Stem cell therapies for muscle disorders. Curr Opin Neurol 2012 Oct; 25[5]:597-603.
119. Crisan M, Deasy B, Gavina M, et al. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol 2008; 86:295-309.
120. Dellavalle A, Maroli G, Covarello D, et al. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat Commun 2011; 2:499.
121. Birbrair A, Zhang T, Wang ZM, et al. Skeletal muscle pericyte subtypes differ in their differentiation potential. Stem Cell Res 2013 Jan; 10[1]:67-84.
122. Cappellari O, Cossu G. Pericytes in development and pathology of skeletal muscle. Circ Res 2013 Jul 19; 113[3]:341-7.
123. Diaz-Manera J, Martinez-Hernandez E, Querol L, et al. Longlasting treatment effect of rituximab in MuSK myasthenia. Neurology 2012 Jan 17; 78[3]:189-93.
124. Birbrair A, Zhang T, Wang ZM, Messi ML, et al. Type-1 pericytes participate in fibrous tissue deposition in aged skeletal muscle. Am J Physiol Cell Physiol 2013 Dec 1; 305[11]:C1098-113.
125. Palumbo R, Sampaolesi M, De Marchis F, et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004 Feb 2; 164[3]:441-9.
126. Sciorati C, Galvez BG, Brunelli S, et al. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J Cell Sci 2006 Dec 15; 119[Pt 24]:5114-23.
127. Ley D, Van Zwieten R, Puttini S, et al. A PiggyBac-mediated approach for muscle gene transfer or cell therapy. Stem Cell Res 2014 Nov; 13[3 Pt A]:390-403.
128. Quattrocelli M, Costamagna D, Giacomazzi G, et al. Notch signaling regulates myogenic regenerative capacity of murine and human mesoangioblasts. Cell Death Dis 2014; 5:e1448.
129. Pannerec A, Formicola L, Besson V, et al. Defining skeletal muscle resident progenitors and their cell fate potentials. Develop 2013 Jul; 140[14]:2879-91.
130. Ikezawa M, Cao B, Qu Z, et al. Dystrophin delivery in dystrophindeficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther 2003 Nov 1; 14[16]:1535-46.
131. Cao B, Zheng B, Jankowski RJ, et al. Muscle stem cells differentiate into haematopoietic lineages but retain myogenic potential. Nat Cell Biol 2003 Jul; 5[7]:640-6.
132. Asakura A, Seale P, Girgis-Gabardo A, Rudnicki MA. Myogenic specification of side population cells in skeletal muscle. J Cell Biol 2002 Oct 14; 159[1]:123-34.
133. Bachrach E, Li S, Perez AL, et al. Systemic delivery of human microdystrophin to regenerating mouse dystrophic muscle by muscle progenitor cells. Proc Natl Acad Sci U S A 2004 Mar 9; 101[10]:3581-6.
134. Tamaki T, Uchiyama Y, Okada Y, et al. Functional recovery of damaged skeletal muscle through synchronized vasculogenesis, myogenesis, and neurogenesis by muscle-derived stem cells. Circulation. 2005 Nov 1; 112[18]:2857-66.
135. Tamaki T, Okada Y, Uchiyama Y, et al. Skeletal muscle-derived CD34+/45- and CD34-/45- stem cells are situated hierarchically upstream of Pax7+ cells. Stem Cells Dev 2008 Aug; 17[4]:653-67.
136. LaBarge MA, Blau HM. Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 2002 Nov 15; 111[4]:589-601.
137. Corbel SY, Lee A, Yi L, et al. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 2003 Dec; 9[12]:1528-32.
138. Brazelton TR, Nystrom M, Blau HM. Significant differences among skeletal muscles in the incorporation of bone marrowderived cells. Dev Biol 2003 Oct 1; 262[1]:64-74.
139. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J Cell Physiol 1996 Mar; 166[3]:585-92.
140. Sassoli C, Pini A, Chellini F, et al. Bone marrow mesenchymal stromal cells stimulate skeletal myoblast proliferation through the paracrine release of VEGF. PLoS One 2012; 7[7]:e37512.
141. Sassoli C, Frati A, Tani A, et al. Mesenchymal stromal cell secreted sphingosine 1-phosphate (S1P) exerts a stimulatory effect on skeletal myoblast proliferation. PLoS One 2014;9[9]:e108662.
142. Torrente Y, Belicchi M, Sampaolesi M, et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004 Jul; 114[2]:182-95.
143. Hollemann D, Budka H, Loscher WN, et al. Endothelial and myogenic differentiation of hematopoietic progenitor cells in inflammatory myopathies. J Neuropathol Exp Neurol 2008 Jul; 67[7]:711-9.
144. Negroni E, Riederer I, Chaouch S, et al. In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 2009 Oct; 17[10]:1771-8.
145. Benchaouir R, Meregalli M, Farini A, et al. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice. Cell Stem Cell 2007 Dec 13; 1[6]:646-57.
146. Torrente Y, Belicchi M, Marchesi C, et al. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 2007; 16[6]:563-77.
147. Meregalli M, Navarro C, Sitzia C, et al. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells. Febs J 2013 Dec; 280[23]:6045-60.
148. Giordani L, Puri PL. Epigenetic control of skeletal muscle regeneration: Integrating genetic determinants and environmental changes. Febs J 2013 Sep; 280[17]:4014-25.
149. Heredia JE, Mukundan L, Chen FM, et al. Type 2 innate signals stimulate fibro/adipogenic progenitors to facilitate muscle regeneration. Cell. 2013 Apr 11; 153[2]:376-88.
150. Dong Y, Silva KA, Zhang L. Glucocorticoids increase adipocytes in muscle by affecting IL-4 regulated FAP activity. Faseb J. 2014 Jun 19.
151. Cordani N, Pisa V, Pozzi L, Sciorati C, Clementi E. Nitric oxide controls fat deposition in dystrophic skeletal muscle by regulating fibro-adipogenic precursor differentiation. Stem Cells 2014 Apr; 32[4]:874-85.
152. Saccone V, Consalvi S, Giordani L, et al. HDAC-regulated myomiRs control BAF60 variant exchange and direct the functional phenotype of fibro-adipogenic progenitors in dystrophic muscles. Genes Dev. 2014 Apr 15; 28[8]:841-57.
153. Skuk D, Roy B, Goulet M, et al. Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells. Mol Ther 2004 Mar; 9[3]:475-82.
154. Quenneville SP, Chapdelaine P, Rousseau J, et al. Nucleofection of muscle-derived stem cells and myoblasts with phiC31 integrase: stable expression of a full-length-dystrophin fusion gene by human myoblasts. Mol Ther 2004 Oct; 10[4]:679-87.
155. Campeau P, Chapdelaine P, Seigneurin-Venin S, et al. Transfection of large plasmids in primary human myoblasts. Gene Ther 2001 Sep; 8[18]:1387-94.
156. Quenneville SP, Chapdelaine P, Skuk D, et al. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther 2007 Feb; 15[2]:431-8.
157. Marg A, Escobar H, Gloy S, et al. Human satellite cells have regenerative capacity and are genetically manipulable. J Clin Invest 2014 Oct; 124[10]:4257-65.
158. Long C, McAnally JR, Shelton JM, et al. Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA. Sci 2014 Sep 5; 345[6201]:1184-8.
159. Li HL, Fujimoto N, Sasakawa N, et al. Precise Correction of the Dystrophin Gene in Duchenne Muscular Dystrophy Patient Induced Pluripotent Stem Cells by TALEN and CRISPR-Cas9. Stem Cell Rep 2015 Jan 13; 4[1]:143-54.
160. Berardi E, Annibali D, Cassano M, Crippa S, Sampaolesi M. Molecular and cell-based therapies for muscle degenerations: a road under construction. Front Physiol 2014; 5:119.
161. Judson RN, Zhang RH, Rossi FM. Tissue-resident mesenchymal stem/progenitor cells in skeletal muscle: collaborators or saboteurs? Febs J 2013 Sep; 280[17]:4100-8.
162. Magliano L, Patalano M, Sagliocchi A, et al. Burden, professional support, and social network in families of children and young adults with muscular dystrophies. Muscle Nerve 2014 Oct 31.
163. Fuoco C, Sangalli E, Vono R, et al. 3D hydrogel environment rejuvenates aged pericytes for skeletal muscle tissue engineering. Front Physiol 2014;5:203.
164. Rizzi R, Bearzi C, Mauretti A, Bernardini S, et al. Tissue engineering for skeletal muscle regeneration. Muscles Ligaments Tendons J 2012 Jul; 2[3]:230-4.
165. Shenoy A, Blelloch RH. Regulation of microRNA function in somatic stem cell proliferation and differentiation. Nat Rev Mol Cell Biol 2014 Sep; 15[9]:565-76.
166. Westholm JO, Lai EC. Mirtrons: microRNA biogenesis via splicing. Biochimie 2011 Nov; 93[11]:1897-904.
167. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 2014 Aug; 15[8]:509-24.
168. Gregory RI, Chendrimada TP, Cooch N, Shiekhattar R. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 2005 Nov 18; 123[4]:631-40.
169. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006 Feb; 38[2]:228-33.
170. Sun Q, Zhang Y, Yang G, et al. Transforming growth factor-betaregulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 2008 May; 36[8]:2690-9.
171. Sharma M, Juvvuna PK, Kukreti H, McFarlane C. Mega roles of microRNAs in regulation of skeletal muscle health and disease. Front Physiol 2014; 5:239.
172. Zhou L, Wang L, Lu L, Jiang P, et al. A novel target of microRNA-29, Ring1 and YY1-binding protein [Rybp], negatively regulates skeletal myogenesis. J Biol Chem 2012 Jul 20; 287[30]:25255-65.
173. Wei W, He HB, Zhang WY, et al. miR-29 targets Akt3 to reduce proliferation and facilitate differentiation of myoblasts in skeletal muscle development. Cell Death Dis 2013; 4:e668.
174. Crippa S, Cassano M, Messina G, et al. miR669a and miR669q prevent skeletal muscle differentiation in postnatal cardiac progenitors. J Cell Biol 2011 Jun 27; 193[7]:1197-212.
175. Quattrocelli M, Crippa S, Montecchiani C, et al. Long-term miR- 669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. J Am Heart Assoc 2013 Aug; 2[4]:e000284.
176. Thery C, Zitvogel L, Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002 Aug; 2[8]:569-79.
177. Mizuno H, Nakamura A, Aoki Y, et al. Identification of musclespecific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy. PLoS One 2011; 6[3]:e18388.
178. Darabi R, Pan W, Bosnakovski D, Baik J, et al. Functional myogenic engraftment from mouse iPS cells. Stem Cell Rev. 2011 Nov; 7[4]:948-57.
179. Quattrocelli M, Palazzolo G, Floris G, et al. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs. J Pathol 2011 Apr; 223[5]:593-603.
180. Darabi R, Arpke RW, Irion S, et al. Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. Cell Stem Cell 2012 May 4; 10[5]:610-9.
181. Filareto A, Parker S, Darabi R, et al. An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells. Nat Commun 2013; 4:1549.
182. Meregalli M, Farini A, Colleoni F, et al. The role of stem cells in muscular dystrophies. Curr Gene Ther 2012 Jun; 12[3]:192-205.